Robin Kramer - Biogen VP Officer
| IDP Stock | EUR 155.25 1.75 1.11% |
Insider
Robin Kramer is VP Officer of Biogen Inc
| Age | 57 |
| Phone | 617 679 2000 |
| Web | https://www.biogen.com |
Robin Kramer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robin Kramer against Biogen stock is an integral part of due diligence when investing in Biogen. Robin Kramer insider activity provides valuable insight into whether Biogen is net buyers or sellers over its current business cycle. Note, Biogen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Biogen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robin Kramer over six months ago Acquisition by Robin Kramer of 45455 shares of Vince Holding subject to Rule 16b-3 |
Biogen Management Efficiency
The company has return on total asset (ROA) of 0.0778 % which means that it generated a profit of $0.0778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2433 %, meaning that it generated $0.2433 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Upchurch | WillScot Mobile Mini | 58 | |
| Joseph Donegan | WillScot Mobile Mini | 72 | |
| Jeffrey Goble | WillScot Mobile Mini | 58 | |
| Jeffrey Sagansky | WillScot Mobile Mini | 67 | |
| Nick Girardi | WillScot Mobile Mini | N/A | |
| Gerard Holthaus | WillScot Mobile Mini | 69 | |
| Sara Dial | WillScot Mobile Mini | 55 | |
| Sally Shanks | WillScot Mobile Mini | 46 | |
| Gary Lindsay | WillScot Mobile Mini | 39 | |
| Rebecca Owen | WillScot Mobile Mini | 57 | |
| Mark Bartlett | WillScot Mobile Mini | 68 | |
| Kimberly McWaters | WillScot Mobile Mini | 55 | |
| Stephen Robertson | WillScot Mobile Mini | 59 | |
| Michael Rose | WillScot Mobile Mini | N/A | |
| Erik Olsson | WillScot Mobile Mini | 57 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 |
Biogen Inc Leadership Team
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Viehbacher, CEO Pres | ||
| Robin Kramer, VP Officer | ||
| Sanjay Jariwala, VP Medical | ||
| Ginger Gregory, Ex Officer | ||
| Anabella Villalobos, Head Sciences | ||
| Susan Esq, Chief VP | ||
| Michael CPA, Ex CFO | ||
| Natacha Gassenbach, Chief Affairs | ||
| Nicole Murphy, Head Technology | ||
| Michael Hencke, Head Relations |
Biogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 41.13 B | |||
| Shares Outstanding | 144.49 M | |||
| Shares Owned By Insiders | 0.68 % | |||
| Shares Owned By Institutions | 89.93 % | |||
| Price To Earning | 14.27 X | |||
| Price To Book | 3.24 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Biogen Stock
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.